Page last updated: 2024-08-23

levormeloxifene and Uterine Prolapse

levormeloxifene has been researched along with Uterine Prolapse in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christiansen, C; Christoffersen, C; Delmas, PD; Riis, BJ; Stakkestad, JA; Warming, L1

Trials

1 trial(s) available for levormeloxifene and Uterine Prolapse

ArticleYear
Adverse effects of a SERM (Levormeloxifene). Safety parameters and bone mineral density 12 months after treatment withdrawal.
    Maturitas, 2003, Mar-28, Volume: 44, Issue:3

    Topics: Bone Density; Double-Blind Method; Endometrium; Female; Follow-Up Studies; Humans; Middle Aged; Pyrrolidines; Receptors, Estrogen; Safety; Selective Estrogen Receptor Modulators; Substance Withdrawal Syndrome; Time Factors; Urinary Incontinence; Uterine Prolapse

2003